Denmark· DK-28104997911
Capecitabine "medac"
A capecitabine product containing capecitabin, registered in Denmark by Medac, Gesellschaft für klinische Spezialpräparate mbH. The same ATC class is registered in 17 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Capecitabine is registered in 17 of 19 countries.
Countries holding a registration under ATC L01BC06 (capecitabine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 10 of them publish a price we can compare per daily dose
Capecitabine · ATC L01BC06
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of capecitabine costs, country by country.
Normalised to the WHO defined daily dose (3 g), the median price runs from $2.73 in United States to $15.27 in Switzerland — a ×5.6 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Capecitabine · price per daily dose (3 g)
USD · FX 28 Sept 2026
- CH Switzerland$15.27
- IT Italy$12.14
- FR France$8.39
- US United States$2.73 (acquisition cost)
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- CAPECITABIN
- Manufacturer
- Medac, Gesellschaft für klinische Spezialpräparate mbH
- Country
- Denmark (DK)
- ATC code
- L01BC06
- ATC class
- Capecitabine
- Defined daily dose
- 3 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28104997911
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
366 interactions on record for capecitabine.
Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Capecitabine · interactions on record
366 records
- 35 severe
- 103 moderate
- 27 minor
- 200 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- Folic acidB03BB01severe
- CladribineL01BB04severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01BC06
Capecitabine, as other registers publish it.
- CanadaACH-CAPECITABINEACCORD HEALTHCARE INC
- CanadaACH-CAPECITABINEACCORD HEALTHCARE INC
- BelgiumBinoda 500 mgAlfred E. Tiefenbacher
- DenmarkCapecitabin "Stada"STADA Arzneimittel AG
- DenmarkCapecitabin "Stada"STADA Arzneimittel AG
- DenmarkCapecitabin "Teva"Teva Pharma B.V.
- DenmarkCapecitabin "Teva"Teva Pharma B.V.
- DenmarkCapecitabin "Zentiva"Zentiva k.s.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e791a2d4-8e97-4565-8226-ccee04e2eaba GET /v1/drugs/e791a2d4-8e97-4565-8226-ccee04e2eaba?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "500 mg",
"auth_role": "MOD",
"dk_drugid": "28104997911",
"substance": "CAPECITABIN",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "41232"
}See everything about capecitabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.